The genetic basis of hypertriglyceridemia
GD Carrasquilla, MR Christiansen… - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review Hypertriglyceridemia is a common dyslipidemia associated with
an increased risk of cardiovascular disease and pancreatitis. Severe hypertriglyceridemia …
an increased risk of cardiovascular disease and pancreatitis. Severe hypertriglyceridemia …
Reducing residual cardiovascular risk in Europe: therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
MJ Chapman, JL Zamorano, KG Parhofer - Pharmacology & therapeutics, 2022 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) and its atherothrombotic complications
impose a substantial disease burden in Europe, representing a cost of€ 210 billion per year …
impose a substantial disease burden in Europe, representing a cost of€ 210 billion per year …
How to handle elevated triglycerides: life after prominent
A Pirillo, AL Catapano - Current Atherosclerosis Reports, 2023 - Springer
Abstract Purpose of Review Hypertriglyceridaemia (HTG) is a common condition
characterised by elevated levels of plasma triglycerides (TG), which are transported in the …
characterised by elevated levels of plasma triglycerides (TG), which are transported in the …
Analysis of the mechanism of action of quercetin in the treatment of hyperlipidemia based on metabolomics and intestinal flora
T Wang, L Liu, J Deng, Y Jiang, X Yan, W Liu - Food & function, 2023 - pubs.rsc.org
Hyperlipidemia (HLP) is one of the main factors leading to cardiovascular diseases.
Quercetin (QUE) is a naturally occurring polyhydroxy flavonoid compound that has a wide …
Quercetin (QUE) is a naturally occurring polyhydroxy flavonoid compound that has a wide …
Prevalence of US adults with triglycerides≥ 150 mg/dl: NHANES 2007–2014
Introduction Hypertriglyceridemia is associated with increased atherosclerotic
cardiovascular disease (ASCVD) event risk, which persists even in statin-treated patients …
cardiovascular disease (ASCVD) event risk, which persists even in statin-treated patients …
Cost-effectiveness of icosapent ethyl for high-risk patients with hypertriglyceridemia despite statin treatment
WS Weintraub, DL Bhatt, Z Zhang, S Dolman… - JAMA Network …, 2022 - jamanetwork.com
Importance The Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial
(REDUCE-IT) demonstrated the efficacy of icosapent ethyl (IPE) for high-risk patients with …
(REDUCE-IT) demonstrated the efficacy of icosapent ethyl (IPE) for high-risk patients with …
Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction
Hypertriglyceridemia is associated with increased cardiovascular disease (CVD) risk. The
Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) …
Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) …
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides
M Pareek, RP Mason, DL Bhatt - Expert Opinion on Drug Safety, 2022 - Taylor & Francis
Introduction In patients at high cardiovascular risk, the rate of events remains elevated
despite traditional, evidence-based lipid-lowering therapy. Residual hypertriglyceridemia is …
despite traditional, evidence-based lipid-lowering therapy. Residual hypertriglyceridemia is …
Icosapent ethyl for primary versus secondary prevention of major adverse cardiovascular events in hypertriglyceridemia: Value for money analysis
Background Icosapent ethyl (IPE) is approved for the prevention of major adverse
cardiovascular events (MACE) in patients with hypertriglyceridemia. However, due to budget …
cardiovascular events (MACE) in patients with hypertriglyceridemia. However, due to budget …
Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta‐Analysis
Background. Dyslipidemia is one of the leading causes of cardiovascular complications in
diabetes mellitus (DM) patients. Though it is a major public health problem in Ethiopia, there …
diabetes mellitus (DM) patients. Though it is a major public health problem in Ethiopia, there …